Stryker reports further growth for 2012 business year

Stryker has published its financial report for the fourth quarter and full-year periods of 2012, during which it was able to achieve encouraging year-on-year growth.

The medical technology firm's net sales for the final quarter of 2012 came to $2.3 billion (1.46 million pounds), up by 5.5 percent year over year, while over the full year its sales total was $8.7 billion, representing a 4.2 percent increase.

Trends contributing to this positive performance include an increased unit volume and changes in the company's product mix, with its reconstructive, MedSurg and neurotechnology and spine divisions all experiencing growth.

For the full year 2013, Stryker is projecting constant currency sales growth in the range of three to 5.5 percent.

Kevin Lobo, president and chief executive officer of Stryker, said: "We are pleased with our fourth-quarter results and look to build on this momentum in 2013."

This comes after the company announced a definitive offer to acquire the Chinese medical products manufacturer Trauson Holdings last week.